Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of Influenza A virus

Background Recombinant hemagglutinin (rHA) and neurominidase (rNA) developed in our investigation are amino acid sequence consensus variants of H1N1 2009 subtype influenza virus strain, also including immunogenic epitopes typical for other influenza virus subtypes (H3N1 and H5N1). Substitutions were made: typical for Russian virus isolates (in HA – S220T, NA – D248N) and in active centers of molecules – R118L, R293L, R368L; C92S, C417S to increase recombinant proteins stability in E. coli. The aim of the present work was to study immunogenicity of the obtained rHA and rNA. Material/Methods Fragments aa 83–469 of NA and aa 61–287 of HA were chosen because they include the main B-cell epitopes and are the minimal structures for correct folding of target proteins. The designed nucleotide sequences were synthesized and purified and the expression of rNA and rNA were analyzed. For immunization and virus challenge we used influenza viruses A/California/04/2009 (H1N1), A/PR/8/34 (H1N1), A/Perth/16/2009 (H3N2), A/Chicken/Kurgan/05/2005 R.G. (H5N1), and B/Florida/04/2006. Specific IgG levels were determined by ELISA in 96-well ELISA plates. Significant differences of survival in mouse groups were analyzed by Mantel-Cox (log-rank) and Gehan-Breslow-Wilcoxon tests. Results The obtained results demonstrate the high immunogenicity and ability of indicated proteins mixture to provide similar cross-protection against influenza viruses of the H1N1 subtype. Conclusions The data obtained suggest efficient pluripotent vaccine creation based on HA and NA conservative regions.

[1]  P. Kelly,et al.  Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. , 2010, Vaccine.

[2]  G. Nabel,et al.  Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination , 2010, Science.

[3]  J. Sidney,et al.  Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus. , 2010, Human immunology.

[4]  T. Yasunaga,et al.  Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition. , 2010, Biochemical and biophysical research communications.

[5]  A. Tempczyk-Russell,et al.  Large-Scale Sequence Analysis of Hemagglutinin of Influenza A Virus Identifies Conserved Regions Suitable for Targeting an Anti-Viral Response , 2010, PloS one.

[6]  Susana López,et al.  Molecular anatomy of 2009 influenza virus A (H1N1). , 2009, Archives of medical research.

[7]  T. P. van den Berg,et al.  Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. , 2009, Vaccine.

[8]  J. Shiloach,et al.  Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. , 2009, Vaccine.

[9]  D. Stallknecht,et al.  Evaluation of a Commercial Blocking Enzyme-Linked Immunosorbent Assay To Detect Avian Influenza Virus Antibodies in Multiple Experimentally Infected Avian Species , 2009, Clinical and Vaccine Immunology.

[10]  Gira Bhabha,et al.  Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.

[11]  N. Veljkovic,et al.  Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control , 2009, BMC structural biology.

[12]  S. Perk,et al.  A universal epitope-based influenza vaccine and its efficacy against H5N1. , 2009, Vaccine.

[13]  Noriko Kishida,et al.  Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses , 2009, PLoS pathogens.

[14]  Boguslaw Stec,et al.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses , 2009, Nature Structural &Molecular Biology.

[15]  I. Šterzl,et al.  Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant. , 2008, Immunology letters.

[16]  E. Neumeier,et al.  Cross-Protection against Homologous Drift Variants of Influenza A and B after Vaccination with Split Vaccine , 2006, Intervirology.

[17]  M. Cox,et al.  Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine , 2005, Vaccine.

[18]  Albert D. M. E. Osterhaus,et al.  Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls , 2005, Journal of Virology.

[19]  L. Young,et al.  Two-step total gene synthesis method. , 2004, Nucleic acids research.

[20]  G. Buchan,et al.  Influenza hemagglutinin peptides fused to interferon gamma and encapsulated in liposomes protects mice against influenza infection. , 2003, Vaccine.

[21]  S. Jeon,et al.  Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus. , 2002, Vaccine.

[22]  R. Webster,et al.  Evolution and ecology of influenza A viruses. , 1992, Current topics in microbiology and immunology.

[23]  K. Majumder.  Ligation-free gene synthesis by PCR: synthesis and mutagenesis at multiple loci of a chimeric gene encoding ompA signal peptide and hirudin. , 1992, Gene.

[24]  B. Murphy,et al.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.

[25]  J. Jorgensen,et al.  Simplified Bioassay Method for Measurement of Flucytosine or Ketoconazole , 1986, Journal of clinical microbiology.

[26]  A. Davis,et al.  Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells , 1985, Molecular and cellular biology.

[27]  A. Davis,et al.  Expression of antigenic determinants of the hemagglutinin gene of a human influenza virus in Escherichia coli. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Livingston,et al.  Evolving Strategies for the Prevention of Influenza Infection , 2012, BioDrugs.

[29]  Influenza fact sheet. , 2003, Releve epidemiologique hebdomadaire.

[30]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[31]  J. Emtage,et al.  The production of vaccines by recombinant DNA techniques. , 1980, Progress in clinical and biological research.